Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

Citations Report

Citations Report - Drug Designing: Open Access [127 Articles]

The articles published in Drug Designing: Open Access have been cited 127 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Drug Designing: Open Access.

Dey A, Chatterjee SS, Kumar V. A bioassay system for pharmacological standardization of Withania somnifera derived herbal remedies. TANG [HUMANITAS MEDICINE]. 2019;9: 1.

Dey A, Chatterjee SS, Kumar V. Triethylene glycol-like effects of Ashwagandha (Withania somnifera (L.) Dunal) root extract devoid of withanolides in stressed mice. Ayu. 2018;39: 230.

Benfenati E, Roncaglioni A, Lombardo A, Manganaro A. Integrating QSAR, Read-Across, and Screening Tools: The VEGAHUB Platform as an Example. InAdvances in Computational Toxicology 2019.

Palaniswamy R, Padma PR. Molecular Docking Studies of Derivatives of Majorana hortensis Leaves against Anti Apoptotic Targets.

Sonego MS, Segatto NV, Damé L, Fronza M, Gomes CB, Oliveira TL, et al. 7-Chloroquinoline-1, 2, 3-Triazoyl Carboxamides Induce Cell Cycle Arrest and Apoptosis in Human Bladder Carcinoma Cells. Investigational new drugs. 2019;6:1.

Waghmare S, Sherkhane A, Gomase V (2015) Computational mapping of MHC class binding nonamers from Fatty-acid and retinol-binding protein 1 of Brugia malayi. Journal of Basic Sciences 1: 45-53.

Mamillapalli V (2016) Nanoparticles for Herbal Extracts. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm 10.

Tashima T (2015) Possibilities of Cancer Chemotherapy Based on Transporter-Conscious Drug Design. J Carcinog Mutagen 6: 2.

Tashima T (2015) Intriguing possibilities and beneficial aspects of transporter-conscious drug design. Bioorganic & medicinal chemistry 23: 4119-4131.

Divya A. Research and Reviews: Journal of Pharmacology and Toxicological Studies.

Bielecka AM, Obuchowicz E (2016) Antidepressant drugs can modify cytotoxic action of temozolomide. European Journal of Cancer Care.

Li L, Wang J, Zang H, Zhang H, Jiang W, et al. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences.

Gautami, J., Nadu, T. Research and Reviews: Journal of Pharmaceutics and Nanotechnology.

Montes, R., Bernat, B., & Srebalus-Barnes, C. (2016). Statistical Applications for Biosimilar Product Development. In Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics: Selected Papers from the 2015 ICSA/Graybill Applied Statistics Symposium, Colorado State University, Fort Collins (pp. 259-277). Springer International Publishing.

Burdick, R. K., LeBlond, D. J., Pfahler, L. B., Quiroz, J., Sidor, L., Vukovinsky, K., & Zhang, L. (2017). Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry.

Chow, S. C., Song, F., & Bai, H. (2016). Sample Size Requirement in Analytical Studies for Similarity Assessment. Journal of Biopharmaceutical Statistics, (just-accepted).

Krause, S. O. Reducing Analytical Method Steps for Accelerated Product.

Burdick, R. K., LeBlond, D. J., Pfahler, L. B., Quiroz, J., Sidor, L., Vukovinsky, K., & Zhang, L. (2017). Analytical Comparability and Similarity. In Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (pp. 329-369). Springer International Publishing.

Burdick, R. K., Thomas, N., & Cheng, A. (2017). Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product. Statistics in Biopharmaceutical Research, (just-accepted).

Burdick, R., Coffey, T., Gutka, H., Gratzl, G., Conlon, H. D., Huang, C. T., ... & Kuehne, H. (2017). Statistical Approaches to Assess Biosimilarity from Analytical Data. The AAPS Journal, 19(1), 4-14.

Top